EP6: Complementary use of mpMRI and genomic testing in prostate cancer
August 3rd 2021
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, discusses the value of using multiparametric MRI and genomic testing together when making treatment decisions in prostate cancer.